Actionable news
All posts from Actionable news
Actionable news in AZN: ASTRAZENECA PLC,

Bristol-Myers reports Q2 profit match, revenue beat

Bristol-Myers Squibb Co. BMY, +0.05% reported a second-quarter profit match and revenue beat on Thursday, but shares plummeted 6.2% in premarket trade on news of rival AstraZeneca's AZN, +0.47% late-stage clinical trial failure, which could carry implication for Bristol-Myers' own cancer drug combination. Earnings for the latest quarter declined to $916 million, or 56 cents per share, from $1.17 billion, or 69 cents per share in the year-earlier...